MedicinesFAQ

Goflikicept Uses, Dosage, Side Effects and more

Goflikicept is under investigation in clinical trial NCT04380519 (Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Infection (COVID-19)).

Attribute Details
Trade Name Goflikicept
Generic Goflikicept
Goflikicept Other Names Goflikicept
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

How Goflikicept works

Goflikicept is a fusion protein that neutralizes interleukin-1B (IL-1B), affecting its signalling pathways. As IL-1B is involved in 'cytokine storm' efects, goflikicept's effects on the molecule inhibits widespread inflammation.

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.